| CAS |
Product Name |
Molecular Formula |
Supplier |
|
6'-METHOXY-[2,3']BIPYRIDINYL-5-YLAMINE |
C11H11N3O |
View |
|
Allofuranoside, methyl 5-amino-5,6-dideoxy-2,3-O-isopropylidene-, ba-L- (8CI) |
C10H19NO4 |
View |
|
2-CHLOROMETHYL-5-PHENYL-3H-THIENO[2,3-D]PYRIMIDIN-4-ONE |
C13H9ClN2OS |
View |
|
3-((4'-(2-METHOXYETHYL)PHENOXY)METHYL)P& |
C16H19BO4 |
View |
|
3-FORMYL-5-METHYLPHENYLBORONIC ACID |
C8H9BO3 |
View |
|
1,9-Anthracenedicarboxylic acid, 1,9-dimethyl ester |
C18H14O4 |
View |
|
2,4,8,10-Tetraoxaspiro[5.5]undecane, 3,9-bis[2-[(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)oxy]-1,1-dimethylethyl]- |
C25H46O10P2 |
View |
|
Pyridine, 4,4'-(1H-imidazole-2,4-diyl)bis- (9CI) |
C13H10N4 |
View |
|
1-(1,3-benzodioxol-5-yl)-3-[(2-methylquinoline-4-carbonyl)amino]urea |
C19H16N4O4 |
View |
|
(6E)-6-[[1-(2-hydroxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-5-imino-2-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one |
C19H17N5O2S |
View |
|
IMAZAMETHABENZ-METHYL |
C16H20N2O3 |
View |
|
ethyl (R)-1-(1-cyclohexyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidine-3-carboxylate |
C18H27N3O4 |
View |
|
ethyl 4-[[2-[6-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4-oxopyran-3-yl]oxyacetyl]amino]benzoate |
C20H20N4O6S |
View |
|
ethyl 2-((3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)thio)butanoate |
C17H17ClN4O2S |
View |
|
7-(2-acetyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)-8-hydroxy-3,4-dihydropyrimido[2,1-b][1,3]thiazin-6(2H)-one |
C20H23N3O5S |
View |
|
(S)-2-chloro-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-6-carboxaMide |
C14H15ClN2O |
View |
|
1,3,4-Thiadiazole, 2-(2-furyl)- (7CI) |
C6H4N2OS |
View |
|
2-(2-CARBOXY-PHENYLAMINO)-3-METHOXY-BENZOIC ACID |
C15H13NO5 |
View |
|
(7Z)-3-(3-chlorophenyl)-7-(pyridin-3-ylmethylidene)-2,4-dihydro-[1,3]thiazolo[3,2-a][1,3,5]triazin-6-one |
C17H13ClN4OS |
View |
|
1-HEXACOSYL ACETATE |
C28H56O2 |
View |
|
CANADIAN BALSAM, NEUTRAL |
n.a. |
View |
|
3-methoxy-4-nitro-N-(4-oxocyclohexyl)benzamide |
C14H16N2O5 |
View |
|
1,2-Benzenediol, 4-[(1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-isoquinolinyl)methyl]- |
C17H19NO4 |
View |
|
5-(4-chlorophenyl)-10-(4-hydroxyphenyl)-1,3,7,7-tetramethyl-8,10-dihydropyrimido[1,2]pyrrolo[4,5-b][1,4]oxazine-2,4-dione |
C25H24ClN3O4 |
View |
|
4-(oxolan-2-ylmethoxy)benzamide |
C12H15NO3 |
View |
|
gusperimus |
C17H38ClN7O3 |
View |
|
2-{[(2-bromo-4-ethylphenoxy)acetyl]amino}-N-ethylbenzamide |
C19H21BrN2O3 |
View |
|
5-METHYL-7,8-DIHYDRO-6H-CYCLOPENTA[E][1,2,3,4]TETRAAZOLO[1,5-A]PYRIMIDINE |
C8H9N5 |
View |
|
1-(2-methyl-1H-imidazol-5-yl)propan-1-one |
C7H10N2O |
View |
|
4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]BENZALDEHYDE |
C13H8F3NO |
View |
|
4-(N-benzyl-N-ethylsulfamoyl)-N-(1,3-dioxoisoindolin-5-yl)benzamide |
C24H21N3O5S |
View |
|
3-methyl-2-{5-[(5-methyl-2-furyl)methylene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}butanoic acid |
C14H15NO4S2 |
View |
|
4-methyl-N-(oxolan-2-ylmethyl)thieno[3,2-b]pyrrole-5-carboxamide |
C13H16N2O2S |
View |
|
1-METHYL-1-PROPENYLMAGNESIUM BROMIDE |
C4H7BrMg |
View |
|
Hexanenitrile, 2-butyl-2-methyl- |
C11H21N |
View |
|
1,2,4-Butanetriol, 3-bromo- |
C4H9BrO3 |
View |
|
1-(2,4-dichlorobenzoyl)-1,4-diazepane |
C12H14Cl2N2O |
View |
|
Tetradecanoic acid, 2-(2-pyrimidinylthio)- |
C18H30N2O2S |
View |
|
26,27,27,27-Tetrafluoro-25-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-24,26-bis(trifluoromethyl)-2,5,8,11,14,17,20,23-octaoxaheptacos-24-ene |
C24H31F17O8 |
View |
|
15(R)-ILOPROST |
C22H32O4 |
View |
|
PHOSPHAZENE BASE P1-T-BU |
C10H27N4P |
View |
|
2-FLUORO-3-IODO-6-METHYLPYRIDINE |
C6H5FIN |
View |
|
4-(2-METHOXY-4-METHYLPHENOXY)PIPERIDINE |
C13H19NO2 |
View |
|
1-Decene |
C10H20 |
View |
|
(R)-(+)-2-Tetrahydrofuroic acid |
C5H8O3 |
View |
|
MC-VC-PAB-MMAF |
C68H103N11O16 |
View |
|
schinifoline |
C17H23NO |
View |
|
Necrosis Inhibitor, IM-54 |
C19H23N3O2 |
View |
|
2-((4-methyl-5-((2-oxobenzo[d]thiazol-3(2H)-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-(trifluoromethyl)phenyl)acetamide |
C20H16F3N5O2S2 |
View |
|
(Z)-3-bromo-N-(3-(prop-2-yn-1-yl)-6-sulfamoylbenzo[d]thiazol-2(3H)-ylidene)benzamide |
C17H12BrN3O3S2 |
View |